Melanoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Active, not recruiting
  • Melanoma
  • Tumor biopsy specimens and blood samples
  • Lille, France
  • +2 more
2021-10-14
Oct 14, 2021
U
Not yet recruiting
  • Renal Cell Carcinoma
  • Melanoma
  • (no location specified)
2021-10-07
Oct 7, 2021
N
Enrolling by invitation
  • Melanoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-10-14
    Oct 14, 2021
    N
    Recruiting
    • Melanoma
    • Intervention Arm
    • Control
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-10-14
    Oct 14, 2021
    N
    Enrolling by invitation
    • Melanoma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2021-10-14
      Oct 14, 2021
      N
      Active, not recruiting
      • Melanoma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2021-10-14
        Oct 14, 2021
        N
        Recruiting
        • Xeroderma Pigmentosum
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2021-10-14
          Oct 14, 2021
          U
          Not yet recruiting
          • Lung Cancer Metastatic
          • +7 more
          • Reduced dose intensity of IO
          • Angers, France
          • +25 more
          2021-10-13
          Oct 13, 2021
          D
          Recruiting
          • Melanoma
          • Tetanus Diptheria Vaccine
          • Polio Boost Immunization
          • Durham, North Carolina
            Duke University Medical Center
          2021-09-30
          Sep 30, 2021
          A
          Active, not recruiting
          • Metastatic
          • +4 more
          • Radiotherapy
          • +2 more
          • Philadelphia, Pennsylvania
            Abramson Cancer Center of the University of Pennsylvania
          2021-10-12
          Oct 12, 2021
          M
          Not yet recruiting
          • Solid Tumor
          • +9 more
          • MEM-288 Intratumoral Injection
          • (no location specified)
          2021-09-29
          Sep 29, 2021
          C
          Recruiting
          • Melanoma
          • +3 more
          • Phoenix, Arizona
          • +17 more
          2021-10-12
          Oct 12, 2021
          B
          Active, not recruiting
          • Melanoma
          • Lipo-MERIT
          • Frankfurt, Germany
          • +3 more
          2021-10-12
          Oct 12, 2021
          K
          Recruiting
          • Solid Tumor, Adult
          • +2 more
          • La Jolla, California
          • +3 more
          2021-10-12
          Oct 12, 2021
          H
          Active, not recruiting
          • Melanoma
          • Tampa, Florida
            H. Lee Moffitt Cancer Center and Research Institute
          2021-10-12
          Oct 12, 2021
          T
          Not yet recruiting
          • Melanoma
          • The intelligent total body scanner (iToBoS)
          • (no location specified)
          2021-09-29
          Sep 29, 2021
          S
          Recruiting
          • Melanoma
          • Carcinoma, Non-Small- Cell Lung
          • Springdale, Arkansas
          • +4 more
          2021-10-08
          Oct 8, 2021
          N
          Completed
          • Sarcoma
          • +3 more
          • Anti-GD2-CAR engineered T cells
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2021-10-09
          Oct 9, 2021
          P
          Recruiting
          • BRAF V600E Unresectable or Metastatic Melanoma
          • +2 more
          • Beijing, Beijing, China
          • +2 more
          2021-10-04
          Oct 4, 2021
          T
          Recruiting
          • Adenocarcinoma
          • +75 more
          • Biomarker Testing (L)
          • +2 more
          • Idaho Falls, Idaho
            Teton Cancer Institute
          2021-10-04
          Oct 4, 2021
          N
          Recruiting
          • ER+ Breast Cancer
          • +18 more
          • Obinutuzumab pretreatment (Gazyva®) Naptumomab estafenatox (ABR-217620; NAP) and durvalumab (IMFINZI; MEDI4736)
          • Naptumomab estafenatox (ABR-217620; NAP) and durvalumab (IMFINZI; MEDI4736)
          • Haifa, Israel
          • +3 more
          2021-10-03
          Oct 3, 2021